Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergencies

Dig Dis Sci. 2014 Jul;59(7):1349-51. doi: 10.1007/s10620-014-3074-x.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acute Radiation Syndrome / prevention & control*
  • Emergencies
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / radiation effects*
  • Humans
  • Interleukin-11 / pharmacology
  • Interleukin-11 / therapeutic use*
  • Radiation-Protective Agents / pharmacology
  • Radiation-Protective Agents / therapeutic use*

Substances

  • Interleukin-11
  • Radiation-Protective Agents